Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

BBS-Bioactive Bone Substitutes

3,887 following
Overview
Ownership
All
Research
Webcasts
Press releases
ShowingAll content types
Regulatory press release3/5/2025, 12:30 PM

BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North

BBS-Bioactive Bone Substitutes
Regulatory press release2/20/2025, 7:00 PM

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatory press release2/17/2025, 11:15 AM

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt

BBS-Bioactive Bone Substitutes

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release2/12/2025, 3:00 PM

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatory press release2/10/2025, 7:00 AM

BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations

BBS-Bioactive Bone Substitutes
Regulatory press release2/6/2025, 1:00 PM

BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatory press release1/31/2025, 2:30 PM

BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors

BBS-Bioactive Bone Substitutes
Regulatory press release12/18/2024, 12:00 PM

Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatory press release12/18/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatory press release12/13/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025

BBS-Bioactive Bone Substitutes
Regulatory press release12/13/2024, 7:30 AM

BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations

BBS-Bioactive Bone Substitutes
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Video12/2/2024, 2:00 PM

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBBS-Bioactive Bone SubstitutesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Regulatory press release11/29/2024, 2:30 PM

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans

BBS-Bioactive Bone Substitutes
Regulatory press release11/29/2024, 2:20 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/29/2024, 1:00 PM

BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatory press release11/26/2024, 3:00 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/22/2024, 5:05 PM

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

BBS-Bioactive Bone Substitutes
Regulatory press release11/22/2024, 5:00 PM

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations

BBS-Bioactive Bone Substitutes
Regulatory press release11/14/2024, 12:00 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/7/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Forum discussions
It makes me wonder about these heavily advertised production lines, where are they since they’re not showing up in the bankruptcy sale, or did they even exist? Tärkeimmät talousuutiset | Kauppalehti – 24 Jun 19 BBS sai valmiiksi viimeiset tuotantolinjan vaiheet CE-merkintää varten...
7/28/2025, 4:24 PM
by Ysiysitoista
5
Yes, the matter can also be monitored to some extent through public services. The Finnish Patent and Registration Office maintains the Virre information service, from which you can obtain the latest trade register extract: https://virre.prh.fi/novus/home?execution=e2s1 Once insolvency...
11/13/2025, 1:30 PM
by Pohjolan Eka
4
After you have sold the shares, or at the latest after the administrator’s final settlement, they are capital losses. Merely delisting is not enough, as was observed with Talvivaara, when the company lingered for years as unlisted ‘Ahtium’ and refused to go bankrupt, so losses could...
11/13/2025, 5:38 AM
by Pohjolan Eka
3
The bankruptcy estate seems to be auctioning off assets again, this time here: https://realisointihuutokauppa.fi/?filter=suosituimmat&city=Reisjärvi&konkurssipesa=BBS-Bioactive%20Bone%20Substitutes%20Oyj%20konkurssipesä%20(0866451-4) Can the estate administration be followed from...
11/13/2025, 8:03 AM
by tomtom
1
So, what about these stocks now, are they probably gone for good? Mainly considering accounting, can one just deduct the investment as a loss, or will the tax authorities still provide some guidance on this?
7/31/2025, 7:11 AM
by Karhukoira
1
Production lines are certainly custom made, so they probably don’t have significant resale value.
7/29/2025, 7:15 AM
by Tmpr2000
1
Taloustaito - Veronmaksajain Keskusliitto ry Sijoittaja on heikoilla pörssiyhtiön konkurssissa Pörssiyhtiöiden konkurssit ovat harvinaisia, mutta saattavat kohdalle osuessaan kalvaa osakkeenomistajaa pitkään. Voi kestää vuosia ennen kuin hän pääsee vähentämään tappion verotuksessaan...
6/14/2025, 5:42 AM
by Ysiysitoista
1
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.